NCR1 and neoplasm: An additional important aspect of this technology is that in addition to promoting NK cell infiltration, it leverages the expression of NKp46 in the tumor microenvironment of multiple solid tumors, overcoming the issue of low CD16 expression on tumor-infiltrating lymphocytes (269).